12:00 AM
 | 
Dec 10, 2012
 |  BC Week In Review  |  Company News  |  Deals

Benitec, uniQure B.V. deal

Benitec granted uniQure non-exclusive, worldwide rights to Benitec's DNA-directed RNAi (ddRNAi) technology in Huntington's disease (HD). In return, Benitec receives...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >